Estimation of Absorbed Doses of Indigenously Produced “Direct-route” Lutetium-177-Labeled DOTA-TATE PRRT in Normal Organs and Tumor Lesions in Patients of Metastatic Neuroendocrine Tumors: Comparison with No-Carrier-Added [177Lu]Lu-DOTA-TATE and the Trend with Multiple Cycles

Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print.

Source: Cancer Biotherapy and Radiopharmaceuticals - December 15, 2021 Category: Cancer & Oncology Authors: Kamaldeep Gaurav Wanage Sarvesh Loharkar Tapas Das Sandip Basu Sharmila Banerjee Source Type: research